Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses - PubMed (original) (raw)
. 2002 Nov 1;169(9):4778-87.
doi: 10.4049/jimmunol.169.9.4778.
Affiliations
- PMID: 12391187
- DOI: 10.4049/jimmunol.169.9.4778
Free article
Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses
Zdenek Hel et al. J Immunol. 2002.
Free article
Abstract
Macaques infected with the SIV strain SIVmac251 develop a disease closely resembling human AIDS characterized by high viremia, progressive loss of CD4(+) T cells, occurrence of opportunistic infection, cachexia, and lymphomas. We report in this study that vaccination with the genetically attenuated poxvirus vector expressing the structural Ags of SIVmac (NYVAC-SIV-gag, pol, env) in combination with priming with DNA-SIV-gag, env resulted in significant suppression of viremia within 2 mo after mucosal exposure to the highly pathogenic SIVmac251 in the majority of vaccinated macaques. The control of viremia in these macaques was long lasting and inversely correlated to the level of both pre- and postchallenge Gag-specific lymphoproliferative responses, as well as to the level of total SIV-specific CD4(+) T lymphocyte responses at the peak of acute viremia as detected by intracellular cytokine-staining assay. Viremia containment also correlated with the frequency of the immunodominant Gag(181-189)CM9 epitope-specific CD8(+) T cells present before the challenge or expanded during acute infection. These data indicate, for the first time, the importance of vaccine-induced CD4(+) Th cell responses as an immune correlate of viremia containment. The results presented in this work also further demonstrate the potential of a DNA-prime/attenuated poxvirus-boost vaccine regimen in an animal model that well mirrors human AIDS.
Similar articles
- Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
Almond N, Berry N, Stebbings R, Preston M, Ham C, Page M, Ferguson D, Rose N, Li B, Mee ET, Hassall M, Stahl-Hennig C, Athanasopoulos T, Papagatsias T, Herath S, Benlahrech A, Dickson G, Meiser A, Patterson S. Almond N, et al. J Virol. 2019 Oct 15;93(21):e00606-19. doi: 10.1128/JVI.00606-19. Print 2019 Nov 1. J Virol. 2019. PMID: 31413132 Free PMC article. - Robust vaccine-elicited cellular immune responses in breast milk following systemic simian immunodeficiency virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeys.
Wilks AB, Christian EC, Seaman MS, Sircar P, Carville A, Gomez CE, Esteban M, Pantaleo G, Barouch DH, Letvin NL, Permar SR. Wilks AB, et al. J Immunol. 2010 Dec 1;185(11):7097-106. doi: 10.4049/jimmunol.1002751. Epub 2010 Nov 1. J Immunol. 2010. PMID: 21041730 Free PMC article. - Virus replication and evolution drive the kinetics and specificity of SIV-specific cytotoxic T lymphocytes.
Geretti AM, Osterhaus AD. Geretti AM, et al. Immunol Rev. 2001 Oct;183:109-14. doi: 10.1034/j.1600-065x.2001.1830109.x. Immunol Rev. 2001. PMID: 11782251 Review. - The role of immunity in protection from mucosal SIV infection in macaques.
Bergmeier LA, Wang Y, Lehner T. Bergmeier LA, et al. Oral Dis. 2002;8 Suppl 2:63-8. doi: 10.1034/j.1601-0825.2002.00014.x. Oral Dis. 2002. PMID: 12164663 Review.
Cited by
- Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag.
Casimiro DR, Wang F, Schleif WA, Liang X, Zhang ZQ, Tobery TW, Davies ME, McDermott AB, O'Connor DH, Fridman A, Bagchi A, Tussey LG, Bett AJ, Finnefrock AC, Fu TM, Tang A, Wilson KA, Chen M, Perry HC, Heidecker GJ, Freed DC, Carella A, Punt KS, Sykes KJ, Huang L, Ausensi VI, Bachinsky M, Sadasivan-Nair U, Watkins DI, Emini EA, Shiver JW. Casimiro DR, et al. J Virol. 2005 Dec;79(24):15547-55. doi: 10.1128/JVI.79.24.15547-15555.2005. J Virol. 2005. PMID: 16306625 Free PMC article. - Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA/MVA vaccine.
Kannanganat S, Nigam P, Velu V, Earl PL, Lai L, Chennareddi L, Lawson B, Wilson RL, Montefiori DC, Kozlowski PA, Moss B, Robinson HL, Amara RR. Kannanganat S, et al. J Immunol. 2010 Dec 15;185(12):7262-73. doi: 10.4049/jimmunol.1000751. Epub 2010 Nov 12. J Immunol. 2010. PMID: 21076059 Free PMC article. - Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus.
van Diepen MT, Chapman R, Douglass N, Galant S, Moore PL, Margolin E, Ximba P, Morris L, Rybicki EP, Williamson AL. van Diepen MT, et al. J Virol. 2019 Apr 3;93(8):e02155-18. doi: 10.1128/JVI.02155-18. Print 2019 Apr 15. J Virol. 2019. PMID: 30760570 Free PMC article. - HIV DNA Vaccine: Stepwise Improvements Make a Difference.
Felber BK, Valentin A, Rosati M, Bergamaschi C, Pavlakis GN. Felber BK, et al. Vaccines (Basel). 2014 May 14;2(2):354-79. doi: 10.3390/vaccines2020354. Vaccines (Basel). 2014. PMID: 26344623 Free PMC article. Review. - A model for testing the immunogenicity of simian immunodeficiency virus and simian-human immunodeficiency virus vaccine candidates in mice.
Xu J, Kelly M, Denning W, Hel Z. Xu J, et al. J Virol Methods. 2009 Jun;158(1-2):70-6. doi: 10.1016/j.jviromet.2009.01.019. Epub 2009 Jan 30. J Virol Methods. 2009. PMID: 19428572 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials